AFIB Stock Overview
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Acutus Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.17 |
| 52 Week High | US$1.09 |
| 52 Week Low | US$0.16 |
| Beta | 0.20 |
| 1 Month Change | -9.41% |
| 3 Month Change | -24.50% |
| 1 Year Change | -80.22% |
| 3 Year Change | -98.85% |
| 5 Year Change | n/a |
| Change since IPO | -99.37% |
Recent News & Updates
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding
Feb 24
Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower
Dec 20Recent updates
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding
Feb 24Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower
Dec 20Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)
Jul 18Acutus files for FDA approval of catheter ablation system AcQBlate
Oct 18Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M
Aug 11Acutus Medical sees Q2 revenue above consensus estimate
Jul 21Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%
Apr 06Acutus Medical: A Name To Slowly Accumulate
Sep 04Acutus Medical, Inc.: Paradigm-Shifting Technology At A Shocking Price
Jul 21Acutus Medical cleared to start atrial fibrillation IDE trial
May 27Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report
May 15Shareholder Returns
| AFIB | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 2.0% | -2.9% | -3.2% |
| 1Y | -80.2% | -3.7% | 19.3% |
Return vs Industry: AFIB underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: AFIB underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| AFIB volatility | |
|---|---|
| AFIB Average Weekly Movement | 23.4% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AFIB's share price has been volatile over the past 3 months.
Volatility Over Time: AFIB's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 232 | Takeo Mukai | www.acutusmedical.com |
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.
Acutus Medical, Inc. Fundamentals Summary
| AFIB fundamental statistics | |
|---|---|
| Market cap | US$4.98m |
| Earnings (TTM) | -US$11.92m |
| Revenue (TTM) | US$7.16m |
0.7x
P/S Ratio-0.4x
P/E RatioIs AFIB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFIB income statement (TTM) | |
|---|---|
| Revenue | US$7.16m |
| Cost of Revenue | US$10.30m |
| Gross Profit | -US$3.14m |
| Other Expenses | US$8.78m |
| Earnings | -US$11.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.40 |
| Gross Margin | -43.79% |
| Net Profit Margin | -166.40% |
| Debt/Equity Ratio | -3,927.0% |
How did AFIB perform over the long term?
See historical performance and comparison